Geron Corporation - GERN Operating Profitability

Graphic logo of Geron (GERN)

Geron Corporation relies on outsourcing for clinical trials and production. Operating profit margins on GURU.Markets illustrate efficiency trends, where -8.20 reflects the latest metric value. The business is developing a unique telomerase inhibitor for hematology, and the precision of its research is guaranteed by strict cold-chain transportation control of biomaterials.

geron.com (GERN): Profitability of Operations from 07/04/2022 to 11/19/2026

Metric breakdowns and analytics for geron.com (GERN)

- price and consensus price forecast:
Fundamental company valuation:GERN, geron.com
Finished products of Geron Corporation

Operating margin is calculated as the ratio of operating profit before taxes and interest to revenue. This coefficient measures cost management efficiency and the business's ability to generate cash flow. The dynamics of operating income react instantaneously to changes in operating expenses. For Geron Corporation (GERN), this indicator reflects the cost of multi-year development and clinical trials. Patent protection for telomerase inhibition allows the company to contain costs, creating a long-term barrier for competitors.